Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
    • Contact Us
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
Home > 2020 > June

Month: June 2020

Use of REMDESIVIR in the current COVID-19 Pandemic

Ijaz Mustafa COVID-19 June 19, 2020January 18, 2022
Use-of-remdesivir-in-the-current-covid-19-pandemic.-F-1Download

Priority Approval/Registration of Drugs Remdesivir and Tocilizumab During the COVID-19 pandemic

Ijaz Mustafa COVID-19 June 15, 2020January 18, 2022
Priority-Approval_Registration-of-Drugs-Remdesivir-and-Tocilizumab-During-the-COVID-19-pandemicDownload

Minutes of 295th meeting of Registration Board Held on 08th to 11th June, 2020.

Murtaza Awan Registration Board June 11, 2020January 13, 2022PER

Minutes of 295th meeting of Registration Board

PDF File Download

Advisory on conduct of clinical trials during COVID-19 pandemic final

Ijaz Mustafa COVID-19 June 1, 2020January 18, 2022
Advisory-on-conduct-of-clinical-trials-during-covid-19-pandemic-finalDownload

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • February 2018
  • November 2017
  • October 2017
  • July 2017
  • June 2017
  • May 2017
  • March 2017
  • November 2016
  • June 2016
  • March 2016
  • May 2014
  • March 2014
  • January 2014
  • October 2013
  • August 2013
  • April 2013
  • October 2012
  • July 2012
  • March 2012
  • February 2002

Meta

  • Log in

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem